Advanced Medical Optics (NYSE: EYE) Investor Update:

(I-Newswire) January 13, 2009 - According to a press release from Monday, January 12, 2009 an investigation on behalf of investors of Advanced Medical Optics, Inc (NYSE: EYE) concerning potential breaches of fiduciary duty by the board of directors of Advanced Medical Optics, Inc (NYSE: EYE) in connection with the proposed acquisition by global health care and medical research giant Abbott Laboratories (NYSE: ABT) was announced. Abbott Laboratories offers Advanced Medical Optics, Inc (NYSE: EYE) shareholder $22 a share. Is that a fair price?

If you currently hold Advanced Medical Optics, Inc (NYSE: EYE) , you have certain options and you should contact the Shareholders Foundation, Inc immediately!

Email: Mail@ShareholdersFoundation.com

or Call us TODAY!

Phone: +1-(858)-779-1554

According to the press release by a law firm the investigation focuses on possible breaches of fiduciary duty and other violations of state law by the board of directors of Advanced Medical Optics, Inc (NYSE: EYE) arising out of their attempt to sell the Company to Abbott Laboratories (NYSE: ABT).
In a press release Abbott Laboratories (NYSE: ABT) announced that it has agreed to acquire Advanced Medical Optics Inc. ( NYSE: EYE) for $1.36 billion. Including debt, the deal is worth about $2.8 billion. Under the terms of the proposed acquisition Abbott Laboratories (NYSE: ABT) will commence a tender offer by Jan. 26, 2009 to purchase all outstanding shares of Advanced Medical Optics Inc. ( NYSE: EYE) at $22 a share. The stock of Advanced Medical Optics Inc. ( NYSE: EYE) yesterday has hit a low of $21.63 and a high of $21.77. EYE was traded on Monday at $21.70, up $12.85 (145.2%). Over the last 52 weeks the stock has ranged from a low of $2.88 to a high of $24.90. EYE shares are rising today after Abbott Laboratories said it will buy the company for $1.36 billion, or $22 per share, more than double the stock's Friday closing price. Thus offered price seems like a big premium (150%) to Friday's closing price of $8.85 of Advanced Medical Optics Inc. ( NYSE: EYE) shares, but CNNMoney.com says that Abbott Laboratories (NYSE: ABT) acquires Advanced Medical Optics Inc. ( NYSE: EYE) "at a discount", because 'shares of Advanced Medical crumbled nearly 90% in September and October'.

Advanced Medical, based in Santa Ana, Calif., is the top equipment maker for laser-vision correction and has a big business for treating cataracts, which is an age-related issue and a market fueled by demographics. Reportedly 60% of people over 60 have cataracts and that the number of people with the eye problem is expected to grow nearly 50% in the next decade, and the cataract business accounts for half of the revenue at Advanced Medical Optics, and 70% of its cataract sales are overseas.

According to the investigation 'the transaction appears to be unfair' and undervalues Advanced Medical Optics, Inc (NYSE: EYE). Advanced Medical Optics, Inc (NYSE: EYE) 's shares traded as high as $42.55 per share on May 18, 2007, $32.01 per share in October 5, 2007 and $24.90 in June 2008.

With the acquisition of Advanced Medical Optics Inc. ( NYSE: EYE), Abbott would immediately become a force in the global eye care market, which leads to the question if there are any antitrust law affecting the deal.

In 2007, Advanced Medical Optics itself made a $4.2billion unsolicited takeover bid for Bausch & Lomb, another top eye care company; but then lowered the bid after one of its largest investors decried the deal. Less than a year after the Swiss drugmaker Novartis reportedly said it would buy up to a 77 per cent stake in Alcon, the eye care market leader, from Nestlé in a two-step transaction worth as much as $39billion.



If you currently hold Advanced Medical Optics, Inc (NYSE: EYE) , you have certain options and you should contact the Shareholders Foundation, Inc immediately!

Email: Mail@ShareholdersFoundation.com

or Call us TODAY!

Phone: +1-(858)-779-1554

or send us your information by mail /facsimile:


Shareholders Foundation, Inc.
Trevor Allen
3111 Camino Del Rio North - Suite 423 -
92108 San Diego
Tel:+1-(858)-779-1554
Fax:+1-(858)-605-5739
Mail@ShareholdersFoundation.com
www.ShareholdersFoundation.com
____________________________________________________________________________
Advertising. At Shareholders Foundation, Inc. we are in contact with a large number of shareholders. We are able to use our size to negotiate with significantly greater efficacy than the single investor with investigators, attorneys, and defendants. At Shareholders Foundation, Inc. we believe that together we can combine the interests of many investors, and use the size of our interest as leverage against the giant corporations. We offer help, support, and assistance for every shareholder by matching shareholder problems with the right legal experts, and finding equitable solutions. Shareholders Foundation, Inc. is comprised of a network of legal experts who both contribute to our vision for the Shareholders Foundation, Inc. and also represent the shareholders in real cases. The Shareholders Foundation, Inc. is not a law firm. Any statements made in press releases, emails or over the phone by any member or personnel employed by Shareholders Foundation, Inc. or by third parties related to the Shareholders Foundation, Inc. is provided for research and guidance purposes only and are not legal advices, as we can not give you legal advice. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact the Shareholders Foundation, Inc at Mail@ShareholdersFoundation.com Or Go To www.ShareholdersFoundation.com To Find Out More

Company Contact Information
Shareholders Foundation, Inc.